Benjamin Li
Mar 5, 2010

Mindshare, Aegis Media, OMD and ZenithOptimedia vie for Xian-Janssen Pharmaceutical media planning account in China

BEIJING - Johnson & Johnson owned Xian-Janssen Pharmaceutical Company has called a media planning review in China.

Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Mindshare, Aegis Media, OMD and ZenithOptimedia are understood to be involved in the pitch.

According to agency sources, the account is a “good size and meaningful” and is worth an estimated US$15 million.

OMD holds the media buying account for Johnson & Johnson. The agency won the business in 2007, which also includes Shanghai Johnson & Johnson Pharmaceuticals and Johnson & Johnson Vision Care.

Motilium and Daktarin are among Xian-Janssen Pharmaceutical's main products in China.


 
Source:
Campaign China

Related Articles

Just Published

26 minutes ago

Asia-Pacific Power List 2024: Thai Minh Diem Tu, ...

Tu sprints towards a community-centric culture and champions the bank’s vision for diversity, wellness and vitality.

29 minutes ago

The bite of success: Lessons from Mars Wrigley in ...

Fadi Abi-Nader, VP of One Demand for Global Emerging Markets at Mars Wrigley, dives into how companies can connect with new audiences, sharing his approach to engaging consumers across diverse markets from the Middle East to Asia.

3 hours ago

Campaign Ad Net Zero Awards 2024 shortlist revealed

The international sustainability awards attracted entries from EMEA, UK, the Americas and APAC–with three shortlists from the latter this year.

11 hours ago

OMG WTF is OAG?

Omnicom's new advertising division purports to be something new, so what does it have on offer? Campaign UK's editor Maisie McCabe explores.